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Background: The term ‘commercial determinants of health’ (CDOH) is increasingly focussing attention upon
the role of tobacco, alcohol and food and beverage companies and others—as important drivers of non-
communicable diseases (NCDs). However, the CDOH do not seem to be clearly represented in the most common
social determinants of health (SDOH) frameworks. We review a wide range of existing frameworks of the
determinants of health to determine whether and how commercial determinants are incorporated into current
SDOH thinking. Methods: We searched for papers and non-academic reports published in English since 2000
describing influences on population health outcomes. We included documents with a formal conceptual
framework or diagram, showing the integration of the different determinants. Results: Forty-eight framework
documents were identified. Only one explicitly included the CDOH in a conceptual diagram. Ten papers discussed
the commercial determinants in some form in the text only and fourteen described negative impacts of
commercial determinants in the text. Twelve discussed positive roles for the private sector in producing
harmful commodities. Overall, descriptions of commercial determinants are frequently understated, not made
explicit, or simply missing. The role of commercial actors as vectors of NCDs is largely absent or invisible in many of
the most influential conceptual diagrams. Conclusions: Our current public health models may risk framing public
health problems and solutions in ways that obscure the role that the private sector, in particular large
transnational companies, play in shaping the broader environment and individual behaviours, and thus
population health outcomes.
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Introduction
Over the last few decades, the complex interactions betweenindividuals, communities and their environments have been a
focus of public health practice and research, and to a lesser extent
policy-making. These interactions are conceptualized through
frameworks, often prominently involving graphical schematic
diagrams illustrating the different determinants of health and how
they inter-relate. The most well-known of these is probably
Whitehead and Dalhgren’s rainbow.1 The value of such
frameworks has been made clear in a report for the World Health
Organization (WHO) Regional Office for Europe, in which
Whitehead and Dalhgren themselves noted that: ‘To be effective in
tackling social inequities in health, policy-makers and practitioners
need a sound understanding of the current evidence about the key
determinants and ways in which health systems can confront them
in different country contexts’.1
As well as being an aid to policy and practice, such frameworks
also serve as a research tool, helping to guide research, e.g. by
helping the development of hypotheses about the relative influence
of these determinants and their interactions. They also help to shape
consideration of policy options, and to identify leverage points for
new interventions, as well as facilitating communication between
academic and non-academic stakeholders.2
However, although such frameworks generally aim to represent
the wider determinants of population health, the commercial or
private sector often does not appear to be explicitly or prominently
included. This is an important omission because there are increasing
calls for greater recognition of the negative impacts on health arising
from commercial activities.3–5 The term commercial determinants of
health (CDOH) has being used to focus attention upon this
concept,3–5 and arises from a recognition that tobacco, alcohol,
and food and beverage companies and other harmful commodity
producers—through both their market and non-market activities—
are important and often-overlooked drivers of non-communicable
diseases (NCDs) in both high-, low- and middle-income countries.5
This is reflected in the Vienna Declaration on Public Health, a
30-year renewal of the Ottawa Charter, which notes that:
it is essential to recognize the growing role of diverse non-state
actors, and especially the importance of distinguishing those that
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pursue public interest objectives from those that pursue
commercial interests, paying particular attention to the difficulties
that can arise with activities promoted as corporate social
responsibility.6,7
Such statements reflect the extent to which commercial actors, often
with resources far in excess of national or non-governmental
counterparts, are seen to be able to influence population health and
wellbeing at the supranational, national, community and individual
levels.
The evidence regarding the nature and extent of influence of
commercial influences on population health is now sufficiently
well established that it would seem odd not to include commercial
actors among the main determinants of health. This article aimed to
review a wide range of existing frameworks of the determinants of
health to determine whether and how commercial determinants
appear to be incorporated into current thinking. The study
objectives were (i) to identify the most well-known and most cited
frameworks, and (ii) to analyze whether and how commercial
influences and the activities of commercial actors were reflected in
conceptual frameworks and diagrams.
The overall aim was to identify the most salient, widely known,
and widely cited frameworks, primarily based on database searches,
and searches of their reference lists, and supplemented with our own
knowledge of the field, as an entry point for discussion of how
thinking and practice around the CDOH can be developed further.
Methods
Search strategy
We initially conducted a scoping search on Medline for ‘social
determinants’+ ‘framework’, from 1 January 2000 to 6 September
2017, resulting in 615 abstracts in total. We used Google Scholar
and searches of the bibliographies of retrieved papers to identify any
relevant non-academic reports (e.g. policy documents) and
frameworks from pre-2000. We supplemented the list with the
authors’ own knowledge of existing frameworks, if they met the
inclusion criteria.
Inclusion criteria
We included in our final analysis any documents if they included
some form of formal conceptual framework graphical figure or
diagram, showing the integration of the different determinants.
We set out to identify framework documents that explicitly set out
the relationship between population health outcomes and/or health
inequalities, and their contributing factors (usually at different levels
from the individual up to the societal level), either to explain the
aetiology of conditions and/or to identify intervention entry points.
Exclusion criteria
We excluded general discussion documents that did not contribute to
overarching frameworks—on the grounds that it is the conceptual
frameworks that are likely to be most influential [such as the
Commission on the Social Determinants of Health (CSDH)
framework].8 For the same reason, we excluded life-course models,
as these tend to be epidemiologically based models of exposures,
rather than analyses of wider influences on individuals and contexts.
We did not include frameworks focussed on a single condition
subpopulation (unless it appeared to be a broadly applicable
framework).
Coding
We sorted the retrieved papers in date order and coded them based
on whether or not they contained reference to the concept of
commercial determinants in a framework, or just in the text. We
also coded instances where the private sector was discussed
positively in the context of a framework or text, and whether the
framework papers included examples of either harmful or positive
influence.
Results
Inclusion of commercial determinants of health
We identified 48 of the most common conceptual frameworks for
the social determinants (see Supplementary table S1; for full list of
references to frameworks, see Supplementary material). Of these
frameworks, only one explicitly included commercial actors, in the
context of the food industry and in the form of a table.9 Ten papers
discussed the concept of commercial determinants in some form in
the text, and fourteen gave examples of corporate influence or
negative impacts. Twelve papers discussed the concept of a
positive, health enhancing role for the private sector (presented as
either text and/or a figure). Exclusions were typically generally
review papers, or opinion papers which mentioned other
frameworks, without proposing or developing conceptual social
determinants of health (SDOH) frameworks themselves.
Health impact of commercial determinants
There was little or no explicit recognition of the scope for analyzing
the health impacts, or roles of, commercial actors in many of these
frameworks (Supplementary table S1), which often focus on broader
structural determinants and include generic terms such as
‘economic’ determinants. Such generic constructs as socioeconomic,
material, work or occupational factors are, of course, highly relevant
to consideration of social determinants, though are largely distinct
from commercial determinants in the form of the consequences of
the business activities of private sector actors, the core subject matter
of this paper.
Even when economic activity and trade was included in a
conceptual diagram, the focus appeared most often to be on the
general macroeconomic environment, and not on the ways in
which specific commercial actors such as transnational corporations
can impact trade agreements, drive consumer demand, provide
employment, shape working conditions, obtain partnerships with
public sector agencies, deliver healthcare services or influence
policies and regulations.10,11 On the other hand, some frameworks
did not even include economic determinants (e.g. the Meikirch
model,12 Supplementary table S1).
References to harmful products
In some cases, even where commercial determinants were included
in the text indirectly (e.g. via foci on tobacco and alcohol) they
appear to be presented as ‘lifestyle factors’ without including the
commercial actors which drive their consumption.13 (e.g. WHO’s
Health in All Policies comprehensive Framework14; Supplementary
table S1). The burden of diseases and injuries consequent on use of
many unhealthy commodities is strongly influenced by factors such
as availability, pricing and advertising as part of a comprehensive
marketing mix, all of which involve decision-making by private
sector actors to further business interests. These were generally
found to be absent from frameworks which include a focus on
individual ‘lifestyles’. In some cases, availability was mentioned in
the text (e.g. the recent Health Foundation report,15) but
marketing—an important commercial determinant—was, across
all frameworks, very rarely mentioned. The US Centre for Disease
Control and Prevention’s (CDC) use of a social ecologic model for
violence prevention16 is an example of the omission of a key
commercial determinant, as the CDC framework does not include
firearms or the firearm industry, and alcohol or the alcohol industry,
despite the roles both play in violence in the USA.17–19 Another such
example is the Framework for Patterning of Women’s Health, which
does not mention determinants such as marketing, although women
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may be disproportionately targeted by some forms of harmful
product marketing, or be at a disproportionate risk from some
products (such as alcohol).20
Although commercial determinants generally do not appear in the
conceptual diagrams, some of the supporting text does describe
them at length. There were ten examples of this (Supplementary
table S1). For example Dahlgren and Whitehead’s ‘Levelling Up
Part 2’ discusses globalization and the influence of major financial
players, as well as specific references to examples of commercial
determinants driving inequalities.21 Similarly, in a framework for
diet-related NCDs, Libman et al.9 explicitly reference the food
industry’s influence, from a micro (community) to a macro
(global) context, and describes the difficulties that arise due to
conflicts of interest between population health and profits. In the
context of health and globalization, Labonté and Torgerson also
discuss corporate power and influence as part of global capitalism
‘is substantially shifting power away from public governing bodies
and towards private economic organisations, the power of which is
defined by national and supranational structures of property
rights’.22 In the same context, Huynen et al.23 note both the role
of public–private partnerships and the role of commercial entities in
promoting NCDs: ‘Although the major chronic diseases are not
transmissible via an infectious agent, the behaviours that
predispose to these diseases can be communicated by advertising,
product marketing and social interactions’.23
The recent report from The Health Foundation and the Institute
of Health Equity on the role of charities in addressing the SDOH ,15
does not directly identify a construct such as commercial
determinants, though does refer to fast food shops and a lack of
available healthy produce as an environmental determinant entitled
‘Our surroundings’.15 Similarly, this report identifies betting shops
and payday loans as increasing the risk of financial difficulty in
deprived areas. Finally, a chapter on ‘Market Responsibility’ in the
CSDH final report8 also recommends that robust public health
leadership is needed to control the circulation of health-damaging
commodities such as tobacco and alcohol, and notes that processed
foods and alcohol are prime candidates for stronger global, regional,
and national regulatory controls. It also highlights the importance of
global governance mechanisms such as the Framework Convention
on Tobacco Control. One of its recommendations is to: ‘Reinforce
the primary role of the state in the provision of basic services
essential to health (such as water/sanitation) and the regulation of
goods and services with a major impact on health (such as tobacco,
alcohol, and food)’.
Discussion
It is clear that consideration of commercial actors is frequently
understated, not made explicit, or simply missing in many of the
most influential conceptual frameworks addressing the SDOH, with
few exceptions (e.g. Libman et al.9 include reference to the food
industry in the context of diet-related NCD). This is particularly
notable in frameworks where corporate influence could potentially
have a major influence—e.g. in a framework concerning childhood
tooth decay that does not include the role of the marketing of sugar
products.24 This invisibility of the commercial determinants is
highly problematic, because the absence from CDOH from many
of these frameworks may obscure commercial sector responsibility
for, and contributions to, health inequalities and population harms,
and unhelpfully deflect attention to other social determinants. The
unintended consequences may be that policymakers, practitioners
and researchers will be led to misdirect their attention to the role
of social policies as the appropriate remedies, whilst commercial
causes of public health problems are ignored or obscured, thus
omitting consideration of the need for closer regulation of
harmful commodities and their producers. We are not optimistic
that there is any significant increase over time in the inclusion of
commercial determinants in these frameworks, though there are too
few examples to be sure.
Within the frameworks we examined, public health most
consistently frames public health problems as being caused by, and
remedied by social policies—housing, education, employment—and
changes in individual behaviours as opposed to the wider
environment. Although the text of documents (like the CDOH
Closing the Gap report) sometimes describes commercial
determinants, this may be insufficient. This is because the
conceptual diagrams (as opposed to their textual descriptions) are
important communication tools, which contribute to shaping how
people (like policymakers) understand problems and frame their
solutions.25 Moreover the commercial determinants that are
included in these frameworks are represented in a wide range of
specific and non-specific ways—including specific commodities
(e.g. alcohol, tobacco, sugar), but also as broader commercial
factors such as ‘trade’ and ‘marketing’; and these are often in turn
mentioned as general environmental ‘influences’, rather than as
being driven by commercial actors.
Possible solutions: putting commercial influences back
in the picture
Buse et al. say that ‘. . .the need for a global collective response and
policy coherence across sectors to effectively hold the commercial
food, beverage, alcohol and tobacco industries (at least partially)
accountable for public health outcomes is clear, the question of
‘how’ requires further consideration’.
Some existing frameworks do offer examples of how CDOH may
be better incorporated and operationalized. For example the WHO’s
2006 report on ‘Health in All Policies’ includes one of the most
thorough considerations of corporate entities of those we
examined, describing the relationships between globalization, the
interests of the private sector, supranational arbitration and health
policy, using examples such as the pitfalls for health policy associated
with ‘Better Regulation’ processes, conflicts of interest in the areas of
food production, weak voluntary agreements to combat obesity, and
marketing of unhealthy products to children. It also includes
examples of successful initiatives to prevent undue corporate
influence, such as tobacco directives (WHO, 2006). Similarly, the
PHE ‘Wider Determinants of Health’ tool includes indicators of the
commercial determinants—such as ‘Density of Fast Food Outlets’,
and licenced alcohol outlets (see https://fingertips.phe.org.
uk/profile/wider-determinants).
These findings suggest that the ‘how’ could involve developing a
more explicit and systematic focus on commercial determinants—
not just in the text, but also in the conceptual diagrams. There may
be several ways to do this. It can be done, e.g. by strengthening
existing SDOH frameworks to explicitly include the commercial
determinants. It can also be done by developing a standalone
model of the commercial determinants (as called for by
Kickbusch, Stuckler and others).3,4,26 Indeed, a growing literature
has attempted to consider the ways in which corporate actors may
influence health.27–29 This includes, e.g. the framework proposed by
Mialon et al.30 for monitoring and analyzing the political activity of
the food industry but clearly this remains largely disconnected from
other social determinants frameworks. This may reflect an unhelpful
separation of the relevant literatures, that if integrated might offer a
clearer and more complete roadmap to improving population
health.
The further development of CDOH within existing social
determinants frameworks may serve to highlight their importance;
will mitigate concerns about generating multiple and competing
agendas; will highlight the potential for regulating corporate
conduct as identifiable (and perhaps more politically feasible) sites
for policy intervention; and will better integrate NCD prevention
policies with the research and policy agendas of actors concerns to
address wider health and social inequalities. It will also be important
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to reflect further on the respective strengths and weaknesses of
seeking to develop standalone frameworks vs. (or as well as)
integrating CDOH into existing wider social determinants and
health equity work. The development of a new standalone model
of the CDOH may however be essential in order to give the field the
necessary impetus, and to help develop the scientific and other
infrastructure to develop it further.
Arguably, the underlying need, however, to develop innovations
in concepts in this area, implies some movement towards
integration. It may also be preferable for any updating of existing
frameworks and any development of new ones to be undertaken in
parallel. Some frameworks are highly targeted to specific policy or
other needs, and one size may not fit all. What is also important is
that as new frameworks continue to emerge, they should be
scrutinized to ensure that they adequately represent the full range
of commercial determinants (including, e.g. gambling and
extractive industries), and do not simply perpetuate their
invisibility, which is convenient for harmful industries while
being harmful to public health. Note too that our review is not a
systematic review, though we do not believe that our findings would
have been significantly different if it had been (e.g. with more
comprehensive searches), as we identified and included all the
major SDOH frameworks.
Conclusions
Public health urgently requires a rapid evolution of existing SDOH
frameworks and thinking in order to extend the core concepts so
that they more fully consider the CDOH.31 It also requires decision-
making by policy actors to hold powerful commercial actors to
account for their actions.32,33 In the absence of this, our current
public health frameworks may risk framing public health problems
and solutions in ways that inadvertently obscure the role that the
private sector, in particular large transnational companies, play in
shaping the broader environment individual behaviours, and
population health outcomes.
The ever-strengthening interest in CDOH therefore requires
strengthened conceptual tools. A recent Lancet editorial ended
with a call to arms on the CDOH: ‘It is time for a conscious
attack on commercial interests and a radical rethinking of the
dominant economic and political models that have too little
interest in equity or social justice’.34
This attack now needs to address itself to the conceptual models
we use to shape our definitions of the problem, its causes, our
evidence-gathering, and our proposed solutions.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 Conceptual frameworks for the ‘social’ determinants of
health have frequently been used to communicate the
complex interactions between individuals, communities
and their environments.
 However the role of the ‘commercial or private sector’ (AKA
the commercial determinants of health)—does not appear to
be explicitly or prominently included in many of the main
social determinants frameworks.
 This study reviewed a wide range of commonly cited and
influential social determinants frameworks. It found that des-
criptions of commercial determinants are frequently under-
stated, not made explicit, or are very often simply missing.
 Our current public health models—and the policies which
they inform—therefore risk framing public health problems
and solutions in ways that inadvertently obscure the role
that the private sector, in particular large transnational
companies, play in shaping population health outcomes.
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Background: Social prescribing initiatives are widely implemented in the UK National Health Service to integrate
health and social care. Social prescribing is a service in primary care that links patients with non-medical needs to
sources of support provided by the community and voluntary sector to help improve their health and wellbeing.
Such programmes usually include navigators, who work with referred patients and issue onward referrals to
sources of non-medical support. This systematic review aimed to assess the evidence of service user outcomes
of social prescribing programmes based on primary care and involving navigators. Methods: We searched 11
databases, the grey literature, and the reference lists of relevant studies to identify the available evidence on
the impact of social prescribing on service users. Searches were limited to literature written in English. No date
restrictions were applied, and searches were conducted to June 2018. Findings were synthesized narratively,
employing thematic analysis. The Mixed Methods Appraisal Tool Version 2011 was used to evaluate the meth-
odological quality of included studies. Results: Sixteen studies met the inclusion criteria. The evidence base is
mixed, some studies found improvements in health and wellbeing, health-related behaviours, self-concepts,
feelings, social contacts and day-to-day functioning post-social prescribing, whereas others have not. The
review also shows that the evaluation methodologies utilized were variable in quality. Conclusion: In order to
assess the success of social prescribing services, more high quality and comparable evaluations need to be
conducted in the future. International Prospective Register of Systematic Reviews number: CRD42017079664
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